The global market for peri-implantitis treatment is on track for substantial expansion, with market value projected to increase from USD 2,689.1 million in 2024 to an impressive USD 5,191.9 million by 2034. This robust growth, driven by a compound annual growth rate (CAGR) of 6.8%, highlights the rising demand for effective peri-implantitis management solutions among both patients and dental professionals.
Peri-implantitis is a serious infectious condition that affects the soft and hard tissues surrounding dental implants, threatening implant stability and overall patient satisfaction. Characterized by inflammation that can lead to progressive bone loss, peri-implantitis poses a significant risk to the long-term success of dental implants—an increasingly popular solution for missing teeth due to their aesthetic and functional benefits. The global rise in dental implant procedures has amplified the need for effective peri-implantitis treatments to ensure implant longevity and minimize complications.
Gain Valuable Market Knowledge: Request a Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d38343337
A recent report from the National Center for Biotechnology Information (NCBI) underscores the urgency of this issue, revealing that in the United States, a two-year cohort study found peri-implantitis affected 34% of patients and 21% of individual implants. These findings highlight the critical need for heightened awareness, preventive measures, and innovative treatment solutions to combat this growing healthcare challenge.
Revenue from peri-implantitis treatment was recorded at USD 2,517.9 million in 2023, reflecting the steady expansion of the market due to increased awareness and the necessity for advanced treatment options. As the demand for effective peri-implantitis management continues to rise, industry stakeholders are expected to ramp up investments in research and development, driving significant advancements in treatment protocols and technologies.
This anticipated growth underscores a pivotal shift in modern dentistry, where peri-implantitis management is increasingly recognized as essential for ensuring the long-term success of dental implants. With more individuals opting for implants as a durable and aesthetically appealing tooth replacement solution, the global healthcare industry remains focused on innovations that enhance treatment efficacy—ultimately improving patient care and implant outcomes worldwide.
“With the demand for dental implants continually increasing, the need for efficient peri-implantitis management is more pressing than ever, The industry is responding with improved treatment options, from antibiotics to regenerative therapies, which will support implant longevity and patient outcomes.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Advancements in Early Detection and Treatment Drive Growth in Peri-Implantitis Market:
The global peri-implantitis market is experiencing significant growth, driven by technological advancements in early detection and innovative treatment options. Peri-implantitis, an inflammatory condition affecting the soft and hard tissues surrounding dental implants, has become an increasing concern with the rising popularity of dental implants. The demand for effective and timely intervention is now at the forefront, pushing both healthcare providers and technology developers to focus on solutions that address prevention, diagnosis, and treatment.
Key Drivers and Trends Shaping the Market:
- Innovation in Diagnostic Tools: Emerging technologies, such as imaging techniques and biomarker analysis, are enhancing the early detection of peri-implantitis. Advanced imaging solutions, including 3D dental scans, allow clinicians to detect subtle changes in tissue around implants, enabling prompt intervention and improved patient outcomes.
- New Therapeutic Approaches: Alongside diagnostics, the development of minimally invasive treatments is gaining traction. Laser therapies and antimicrobial photodynamic therapy (aPDT) offer effective, low-impact options for addressing infection and inflammation. These options reduce recovery time and promote better patient compliance, making them favorable alternatives to more invasive methods.
- Focus on Preventive Care: With increasing awareness among patients and healthcare providers, preventive strategies are becoming integral in peri-implant care. Regular screening, maintenance protocols, and educational programs on oral hygiene practices are essential in minimizing the risk of peri-implantitis and improving implant longevity.
Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report! https://www.futuremarketinsights.com/reports/peri-implantitis-treatment-market
Key Takeaways: Projected Economic Growth
- India is poised for substantial growth with a projected 7.7% Compound Annual Growth Rate (CAGR).
- China is expected to maintain a strong growth trajectory at 6.8% CAGR.
- South Korea is projected to grow at a solid 5.4% CAGR.
- United States is forecast to experience a more moderate growth rate of 2.1% CAGR.
- Germany is projected to grow at a similar pace to the US, with a 2.3% CAGR.
Competitive Landscape:
To maintain a competitive edge, key players in the peripheral microcatheter market are implementing several strategic initiatives. These include:
- Robust R&D Investment: Companies are significantly investing in research and development to improve material composition and design, aiming to enhance catheter performance and safety.
- Strategic Partnerships and Acquisitions: Forming strategic alliances and acquiring smaller companies enables these players to expand their product portfolios and gain access to emerging technologies.
Recent Industry Developments:
- Fotona Expands Training Capabilities: On July 6, 2024, Fotona announced the opening of the Laser & Health (LA&HA) Academy Training Center in Malaysia. This center aims to enhance knowledge, foster collaboration, and promote clinical excellence in the field of laser dentistry.
- Straumann Strengthens Peri-Implantitis Treatment Portfolio: On February 23, 2024, Straumann completed the acquisition of GalvoSurge, a Swiss medical device company specializing in dental implant care and maintenance solutions. GalvoSurge’s innovative approach to peri-implantitis treatment, including its CE-marked device launched in 2020, will further bolster Straumann’s offerings in this area.
Key Players of Peri-implantitis Treatment Industry:
- Pfizer Inc.
- Cadila Pharmaceuticals
- R N. Laboratories
- Triveni Chemicals
- Basic Pharma Life Sciences
- Prachi Pharmaceuticals
- Healthy Life Pharma Private Limited
- Straumann AG
- Fotona
Advantage Healthcare Insights to Outpace Competitors! https://www.futuremarketinsights.com/industry-analysis/therapy-area
Key Segments of Peri-implantitis Treatment Industry:
By Method Type:
In terms of method type, the industry is divided into surgical treatment of peri-implantitis (mechanical debridement, laser debridement, open flap debridement, open flap debridement with guided bone generation), non-surgical treatment of peri-implantitis (surface debridement, antibiotics (chlorhexidine digluconate), others.
By End User:
In terms of end user, the industry is segregated into peri-implantitis treatment in hospitals and peri-implantitis treatment in dental clinics
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
